SEBI Registration NO.---- INA000001530 Investment in stock and commodity market are subject to market risk. Please do not trade on those tips which are not provided through SMS or messenger.

Top Stocks to be Focused for 17 April 2017

Top Stocks to be Focused for 17 April 2017

Reliance Infrastructure: Anil Ambani-led Reliance Infrastructure on Saturday reported consolidated net profit of Rs 40.94 crore for the March quarter against a net loss of Rs 327.41 crore a year ago. The company’s total income for the January-March 2017 declined to Rs 6,145 crore from Rs 6,910 crore a year-ago.

DCB Bank: Private sector DCB Bank has reported 24.3 per cent fall in net profit at Rs 53 crore for the fourth quarter ended March of 2016-17 fiscal. The bank had reported net profit of Rs 70 crore in January-March quarter of 2015-16.

RIIL: Reliance Industrial Infrastructure LtdBSE 0.06 % (RIIL) on Friday reported an exponential rise of 140.1 per cent in its net profit for the fourth quarter (Q4) of 2016-17. The company’s net profit rose to Rs 7.30 crore from Rs 3.04 crore reported for the corresponding quarter of 2015-16.

Reliance Power: The company on Thursday reported a 250 per cent rise in consolidated net profit at Rs 215.90 crore for the fourth quarter ended March 31, 2017 against Rs 61.55 crore in the corresponding quarter last year.

Gruh Finance BSE -0.40 % and Orient Paper : Gruh Finance and Orient Paper & Industries will announce their financial results for the quarter ended March 31, 2017 on Monday.

Bajaj Corp: FMCG maker Bajaj Corp Ltd on Thursday reported a decline of 2.93 per cent in standalone net profit at Rs 52.66 crore for the fourth quarter ended March. It had posted a standalone net profit of Rs 54.25 crore in the January-March quarter of 2015-16, Bajaj Corp Ltd said in a BSE filing.

Manaksia Industries: Net profit of Manaksia Industries declined 55.82 per cent to Rs 6.30 crore in the quarter ended March 2017 as against Rs 14.26 crore during the previous quarter ended March 2016.

Federal Bank: The bank is planning to sell up to 26 per cent stake in its non-bank finance unit, Fedbank Financial Services, to private equity firms to raise Rs 400-500 crore, two people with direct knowledge of the matter said.

Dr Reddy’s Laboratories: Drug firm Dr Reddy’s Laboratories on Friday said the US health regulator has completed inspection of its Srikakulam facility without making any observations.

Cairn India: The company, along with its partners is set to invest Rs 3,240 crore in the Ravva Fields in the Krishna-Godavari Basin, to undertake 20 Developmental Wells and for setting up related infrastructure, as the oil and gas production is dwindling from the existing wells.

2
 
error: Content is protected !!